| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Barinthus Biotherapeutics plc.
13D
BRNS · 91864C107
|
6.7% |
4/13/2026
Event 2/3/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.